Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S. Yu. Golokhvastov"'
Autor:
I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 10, Iss 3, Pp 97-102 (2018)
This paper describes a case of Balo's concentric sclerosis, a rare demyelinating disease of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years, there has been a more favorable clinical course of Bal
Externí odkaz:
https://doaj.org/article/1cfa7ee0cc13438a862bcb558ab5acf1
Autor:
R. V. Andreev, A. V. Smolyannikova, S. Yu. Golokhvastov, A. Yu. Emelin, V. Yu. Lobzin, I. V. Litvinenko, N. V. Tsygan, D. N. Frunza, M. N. Markova, N. A. Lupina
Publikováno v:
Russian neurological journal. 27:70-76
The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been
Autor:
M. M. Odinak, I. A. Voznyuk, M. A. Piradov, S. A. Rumyantseva, A. N. Kuznetsov, S. N. Yanishevskiy, S. Yu. Golokhvastov, N. V. Tsygan
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 4, Iss 1, Pp 20-28 (2017)
The multicentral pilot clinical trial of gliatilin in treatment ofacute ischemic stroke was held in 20062008 in Russia. The trialinvolved 122 patients, who received basic treatment and gliatilinduring 3 months after the stroke onset (115 days 2000 mg
Externí odkaz:
https://doaj.org/article/48ac7cac6382479e8d8023e6571aa654
Autor:
M. M. Odinak, I. A. Voznyuk, S. N. Yanishevsky, S. Yu. Golokhvastov, N. V. Tsygan, A. Yu. Polushin, R. V. Andreev, D. A. Mirnaya
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 8, Iss 1, Pp 9-15 (2016)
The main purpose of examination of patients before thrombolytic therapy for ischemic stroke (IS) is to timely identify contraindications to the use of recombinant tissue plasminogen activator.Objective: to estimate opportunities and benefits in apply
Externí odkaz:
https://doaj.org/article/2c472e48acc643ca8a54ed3e6a378d1c
Autor:
Odinak Mm, A V Ryabtsev, S. N. Yanishevsky, Tsygan Nv, I. V. Litvinenko, S. Yu. Golokhvastov, S. V. Kolomentsev, R. V. Andreev
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 27:29-40
The history of reperfusion treatment for ischemic stroke was officially recognized in 1996, when the use of systemic thrombolytic therapy (TLT) was authorized in the United States of America and the first clinical guidelines were published (American
Autor:
G. N. Bisaga, R. F. Gimadutdinov, I. V. Litvinenko, V. Yu. Lobzin, P. S. Dynin, V. S. Chirsky, S. Yu. Golokhvastov
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 10, Iss 3, Pp 97-102 (2018)
This paper describes a case of Balo's concentric sclerosis, a rare demyelinating disease of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years, there has been a more favorable clinical course of Bal
Autor:
D F, Chritinin, V K, Shamrey, E S, Kurasov, I V, Litvinenko, N V, Tsygan, S Yu, Golokhvastov, A V, Ryabtsev
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:13
To study neurological and mental disorders associated with the inapparent and mild course of COVID-19.The study included 50 patients (mean age 35.2±11.4 years) admitted to a psychiatric hospital due to depressive spectrum disorders. Patients were di
Autor:
Tsygan Nv, O S Karpova, I. V. Litvinenko, R. V. Andreev, S. N. Yanishevsky, S. Yu. Golokhvastov, V.A. Yakovleva
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(12. Vyp. 2)
Nowadays, there are two complementary approaches to treatment of patients with ischemic stroke: reperfusion and neuroprotection. The main purpose of neuroprotection is to intervene ischemic cascade at every stage of the pathological process and thus
Publikováno v:
Neuroscience and Behavioral Physiology. 45:600-604
The aim of the present work was to use MR spectroscopy to assess the quantitative contents and ratios of different metabolites in the infarct nucleus, ischemic penumbra, and unaltered tissue in the opposite hemisphere in patients in the acute period
Publikováno v:
Neuroscience & Behavioral Physiology; Jun2015, Vol. 45 Issue 5, p600-604, 5p